ProtoKinetix (OTCMKTS:PKTX) Stock Crosses Above Fifty Day Moving Average – What’s Next?

ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s stock price passed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. ProtoKinetix shares last traded at $0.0001, with a volume of 50,000 shares changing hands.

ProtoKinetix Trading Down 100.0%

About ProtoKinetix

(Get Free Report)

ProtoKinetix, Inc is a biotechnology company focused on developing therapeutic products and technologies for regenerative medicine and cell preservation. The company’s research is centered on proprietary synthetic glycopeptides intended to help protect cells from stress and improve cell survival.

ProtoKinetix’s principal product candidate is PKX-001, an engineered glycopeptide being evaluated for potential applications in areas such as cell and tissue preservation, regenerative medicine, and the support of cellular therapies.

Recommended Stories

Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.